ALHC

SEC source: 0001628280-26-065321 · wk-form4_1791403206.xml · nonDerivative · entry 1

Kim Hyong · CIK 0001993255 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 299,271

F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $8.18 to $8.44. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-062740 · wk-form4_1789763370.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,080,305

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $8.285 to $8.915. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-062329 · wk-form4_1789595865.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 590,766

F1 · kind: Date of Rule 10b5-1 plan adoption: 05/27/2026

F2 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-26-061621 · wk-form4_1789173662.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 794,606

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.394 to $13.17. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-061620 · wk-form4_1789173489.xml · nonDerivative · entry 2

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,223,473

F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.394 to $13.17. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-061620 · wk-form4_1789173489.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 618,166

F1 · kind: Date of Rule 10b5-1 plan adoption: 05/27/2026

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.71 to $13.21. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-26-057635 · wk-form4_1787083295.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 917,313

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/13/2026

SEC source: 0001628280-26-055418 · wk-form4_1786400056.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 790,766

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.62 to $14.30. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-26-048498 · wk-form4_1784235242.xml · derivative · entry 3

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 152,068 shares

Expires 2032-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Options vested 25% on each of the first four anniversaries of the grant date (03/08/2022), subject to the reporting person's continued service to the Company as of the applicable vesting date.

SEC source: 0001628280-26-048498 · wk-form4_1784235242.xml · nonDerivative · entry 2

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 922,313

F1 · kind: Date of adoption of Rule 10b5-1 plan: 3/13/26

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.29 to $21.14. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-048498 · wk-form4_1784235242.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,099,381

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Date of adoption of Rule 10b5-1 plan: 3/13/26

SEC source: 0001628280-26-048170 · wk-form4_1784062026.xml · nonDerivative · entry 2

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 1,088,766

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025

F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.55 to $20.84. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-26-048170 · wk-form4_1784062026.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 1,107,122

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.55 to $20.54. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-26-046575 · wk-form4_1782938299.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director · EVP, Corporate Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,103,816

F1 · kind: Date of adoption of Rule 10b5-1 plan: 03/04/2026

SEC source: 0001628280-26-046944 · wk-form4_1783024232.xml · nonDerivative · entry 1

Hochradel Shane J. · CIK 0002137394 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,719

F1 · shares: Represents 87,719 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of March 13, 2027, 2028 and 2029, subject to the reporting person's continued service to the Company as of the applicable vesting date.

SEC source: 0001628280-26-045734 · wk-form4_1782504085.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director · EVP, Corporate Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,128,816

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/04/2026

SEC source: 0001628280-26-044253 · wk-form4_1781812958.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director · EVP, Corporate Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,153,816

F1 · kind: Date of adoption of Rule 10b5-1 plan: 03/04/2026

SEC source: 0001628280-26-043369 · wk-form4_1781567800.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 947,313

F1 · kind: Date of Rule 10b5-1 plan adoption: 05/22/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.19 to $19.80. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-043335 · wk-form4_1781561010.xml · nonDerivative · entry 1

Kim Hyong · CIK 0001993255 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 331,750

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/13/2026

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.57 to $20.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-042830 · wk-form4_1781294697.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director · EVP, Corporate Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,178,816

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/04/2026

SEC source: 0001628280-26-042824 · wk-form4_1781294599.xml · nonDerivative · entry 2

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 1,386,766

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025

F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.12 to $20.89. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · balance_after: Balances in column 5 reflect the transfer of 176,125 shares held directly by Mr. Kao to the JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

F4 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-26-042824 · wk-form4_1781294599.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 1,609,830

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.12 to $20.11. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · balance_after: Balances in column 5 reflect the transfer of 176,125 shares held directly by Mr. Kao to the JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

F4 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-26-041910 · wk-form4_1781036355.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,203,816

F1 · shares: Represents 122,807 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of March 13, 2027, 2028 and 2029, subject to the reporting person's continued service to the Company as of the applicable vesting date.

SEC source: 0001628280-26-041913 · wk-form4_1781036447.xml · nonDerivative · entry 1

Kent Mark D. · CIK 0001982370 · President - MSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,567

F1 · shares: Represents 87,719 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of March 13, 2027, 2028 and 2029, subject to the reporting person's continued service to the Company as of the applicable vesting date.

SEC source: 0001628280-26-040005 · wk-form4_1780441082.xml · nonDerivative · entry 1

Kent Mark D. · CIK 0001982370 · President - MSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,848

SEC source: 0001628280-26-036489 · wk-form4_1779222562.xml · nonDerivative · entry 3

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 977,313

F4 · kind: Represents a bona fide gift to a charitable donor advised fund.

SEC source: 0001628280-26-036489 · wk-form4_1779222562.xml · nonDerivative · entry 2

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 997,313

F3 · kind: Represents a bona fide gift to a family member.

SEC source: 0001628280-26-036489 · wk-form4_1779222562.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 998,813

F1 · kind: Date of Rule 10b5-1 plan adoption: 05/22/25

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.70 to $16.66. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-034621 · wk-form4_1778703563.xml · nonDerivative · entry 2

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 1,508,641

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025

F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.22 to $17.70. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-26-034621 · wk-form4_1778703563.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 1,525,748

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.22 to $17.16. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-26-025344 · wk-form4_1776300091.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,028,813

F1 · kind: Date of Rule 10b5-1 plan adoption: 05/22/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.76 to $21.07. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-024978 · wk-form4_1776119869.xml · nonDerivative · entry 3

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 1,806,641

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025

F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.26 to $21.00. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-26-024978 · wk-form4_1776119869.xml · nonDerivative · entry 2

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 1,888,940

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025

F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $21.31 to $21.49. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-26-024978 · wk-form4_1776119869.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 1,902,741

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.31 to $21.30. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-26-024289 · wk-form4_1775684887.xml · nonDerivative · entry 2

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 2,104,641

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025

F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $21.18 to $21.56. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-26-024289 · wk-form4_1775684887.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 2,222,400

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.18 to $21.17. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-26-024291 · wk-form4_1775685070.xml · nonDerivative · entry 1

Head James M · CIK 0001842028 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,495

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

SEC source: 0001628280-26-022893 · wk-form4_1775081790.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 305,451

F1 · kind: Date of adoption of Rule 10b5-1 plan: 09/08/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.57 to $17.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-020614 · wk-form4_1774301808.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 2,354,641

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/25

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.07 to $17.81. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-26-019906 · wk-form4_1773959086.xml · nonDerivative · entry 2

Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 148,628

F3 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025

F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.18 to $18.30. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-019916 · wk-form4_1773960052.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 323,464

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-019906 · wk-form4_1773959086.xml · nonDerivative · entry 1

Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,230

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-019921 · wk-form4_1773960255.xml · nonDerivative · entry 1

Burzacchi Sebastian · CIK 0002002259 · COO - Mgmt Services Org

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 258,630

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-019913 · wk-form4_1773959979.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,058,813

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-019910 · wk-form4_1773959860.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,784,868

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-019918 · wk-form4_1773960141.xml · nonDerivative · entry 1

Kim Hyong · CIK 0001993255 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 367,701

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-019908 · wk-form4_1773959198.xml · nonDerivative · entry 1

Scavo Robert L. · CIK 0001975024 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 487,685

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-018880 · wk-form4_1773782088.xml · nonDerivative · entry 2

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,095,562

F2 · kind: Date of Rule 10b5-1 plan adoption: 05/22/2025

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.12 to $17.60. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-26-018892 · wk-form4_1773782389.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 348,589

F1 · shares: Represents 51,501 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

SEC source: 0001628280-26-018909 · wk-form4_1773782650.xml · nonDerivative · entry 1

Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,230

F1 · shares: Represents 23,543 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.